The Trial The ATTAIN-MAINTAIN trial enrolled patients who had achieved substantial weight loss that had plateaued while taking weekly injectable GLP-1s in the SURMOUNT-5 trial
The original aspartic acid (D) and the substituted asparagine (N) have different chemical properties, which likely relates to the reduced activity and affinity of this allozyme
Remember, if you ever feel uncertain about your injection process or experience unusual symptoms, professional advice is just a click away
However, since semaglutide treatment usually lasts months, regularly having low protein during that time can lead to a series of issues that are harder to fix
Mller M, Hernndez MAG, Goossens GH, et al
Este tratamiento ofrece una alternativa eficaz para quienes buscan un mejor control de su diabetes tipo 2, adaptndose a diferentes necesidades mdicas y estilos de vida